Exercise may boost blood vessel function in older veterans with Pre-Diabetes
NCT ID NCT01176578
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether 6 months of aerobic exercise can improve blood vessel health and cell function in older veterans with impaired glucose tolerance, a pre-diabetic condition. Researchers will measure changes in endothelial progenitor cells and muscle blood flow. The goal is to understand how exercise might help prevent diabetes-related complications.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Aerobic exercise training
- What this could lead to
- If successful, this study could show that regular aerobic exercise improves blood vessel health and glucose metabolism in older adults at risk for diabetes.
- What could go wrong
- This is an early-stage observational study with only 70 participants, so results may not apply to everyone. Exercise adherence and individual health differences could affect outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2011
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 50-80 * Non-smoker * If woman, postmenopausal \>1 year Exclusion Criteria: * History of heart disease or stroke * Cancer * Poorly controlled hypertension or dyslipidemia * Kidney or Liver diseases
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 2 diabetes mellitus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baltimore VA Medical Center
Baltimore, Maryland, 21201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill takes aim at stubborn blood sugar
- Gene therapy shots aim to save legs from amputation in diabetes
- New pill takes aim at blood sugar in diabetes
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Weekly shot aims to melt away pounds in obesity fight
- Smart pillbox aims to keep patients on track